Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan CEO Defends Tysabri Sales, Citing ‘Good Progress’
Elan CEO Defends Tysabri Sales, Citing ‘Good Progress’
Elan CEO Defends Tysabri Sales, Citing ‘Good Progress’
Submitted by
admin
on December 22, 2008 - 10:26am
Source:
WSJ Online
News Tags:
Elan
Biogen Idec
Tysabri
MS
Kelly Martin
Headline:
Elan CEO Defends Tysabri Sales, Citing ‘Good Progress’
Do Not Allow Advertisers to Use My Personal information
